Skip to content

The comparison between oral modafinil and placebo to accelerate the rate of improvement in the level of consciousness in adult patients with moderate or severe acute traumatic brain injury admitted in intensive care units of Rajaee Trauma Center in 1399-1400

The comparison between oral modafinil and placebo to accelerate the rate of improvement in the level of consciousness in adult patients with moderate or severe acute traumatic brain injury admitted in intensive care units of Rajaee Trauma Center in 1399-1400

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141009019470N105
Enrollment
314
Registered
2021-01-25
Start date
2021-02-02
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain injury. Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: Patients in the drug group receive 200 mg of oral modafinil daily (Torrent Pharma, UK) dissolved in 10 cc of plain water at 9 am through a tube placed in the stomac

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who have a GCS score between 6 and 12 at the time of initiation of NG tube feeding in the ICU Head AIS score above 3 on the first day of ICU stay, the AIS score of the other parts below 3 on the first day of ICU stay, the consent of the patient's guardian or legal guardian Consent of the patient's guardian or legal guardian Age over 18 years and under 70 years Patients with moderate or severe head injury who are admitted to intensive care

Exclusion criteria

Exclusion criteria: Severe side effects such as severe agitation or anaphylactic reaction to modafinil Occurrence of seizures Incidence of death or brain death multiple trauma Injury Severity Score less than 20 History of psychotropic and brain stimulant drug abuse and alcoholism History of severe liver failure History of seizures History of Anxiety Disorders Cardiac or respiratory recurrence in the first 6 days of hospitalization

Design outcomes

Primary

MeasureTime frame
Unawareness condition. Timepoint: At intervals of one, three and six months after discharge from the hospital. Method of measurement: GOS-E (Glasgow Outcome Scale-Extended).

Secondary

MeasureTime frame
Agitation. Timepoint: Every 4 hour. Method of measurement: RASS (Richmond Agitation-Sedation Scale).;Level of Conciseness. Timepoint: Every 8 hours. Method of measurement: GCS(Glasgow Coma Score).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Zand

Shiraz University of Medical Sciences

zandfarid@yahoo.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026